Sfoglia per Autore  ZAMBELLI, ALBERTO

Opzioni
Mostrati risultati da 1 a 20 di 181
Titolo Tipologia Data di pubblicazione Autori File
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 01 - Articolo su rivista 2025 Zambelli A. +
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway 01 - Articolo su rivista 2025 Zambelli A. +
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists 01 - Articolo su rivista 2025 Zambelli A. +
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses 01 - Articolo su rivista 2025 Zambelli A. +
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 01 - Articolo su rivista 2025 Zambelli A. +
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patients 01 - Articolo su rivista 2025 Zambelli A. +
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 01 - Articolo su rivista 2025 Merlo, FedericoSala, IsabellaPagan, EleonoraZambelli, AlbertoBagnardi, Vincenzo +
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 01 - Articolo su rivista 2024 Zambelli, A +
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study 01 - Articolo su rivista 2024 Cazzaniga M. E.Zambelli A. +
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 01 - Articolo su rivista 2024 Zambelli, A +
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 01 - Articolo su rivista 2024 Zambelli, A +
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients 01 - Articolo su rivista 2024 Zambelli, A +
Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research 01 - Articolo su rivista 2024 Zambelli, A +
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions 01 - Articolo su rivista 2024 Zambelli, A +
Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding ‘Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3’ by M. P. Goetz et al 01 - Articolo su rivista 2024 Zambelli A. +
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort 01 - Articolo su rivista 2024 Zambelli A. +
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy 01 - Articolo su rivista 2024 Zambelli A. +
BRCA Testing for Patients Treated in Italy: A National Survey of Breast Centers Associated with Senonetwork 01 - Articolo su rivista 2024 Zambelli A. +
Corrigendum to “Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis” [Crit. Rev. Oncol./Hematol. 204 (2024) 104527](S1040842824002701)(10.1016/j.critrevonc.2024.104527) 99 - Altro 2024 Zambelli A. +
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial) 01 - Articolo su rivista 2024 Zambelli A. +
Mostrati risultati da 1 a 20 di 181
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile